Compartment allergy

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Term for the allergological phenomenon of an "organ-limited" application-dependent allergy manifestation. Exemplary is the heparin allergy with allergic, dermatitic reactions at the injection sites. These patients tolerate intravenous heparin administration despite "cutaneous" sensitization. Purely theoretically, a hematogenic "contact allergic dermatitis" would be expected.

In contrast to subcutaneous injection, heparin molecules remain in the blood circulation after intravenous administration or are rapidly excreted, but do not lead to a dermatitic inflammation phenomenon at the injection sites.

This special feature of an application-dependent allergy manifestation is also observed with thiomersal (skin contact vs. intramuscular vaccination), nickel (skin contact vs. orthopaedic implants).

LiteratureThis section has been translated automatically.

  1. Trautmann A (2006) Heparin allergy: Late type allergy to subcutaneous heparin injection. Allergo J 15: 501-506
  2. Trautmann A (2006) Allergy to Heparin s.c. What are the alternatives to thrombosis prophylaxis? dermatology 22:311, 314, 316-317
  3. Trautmann A (2018) Heparin allergies - recommendations for diagnostics and patient management... Allergo J Int 27: 122-125
  4. Weberschock T et al (2010) The risk of cross-reactions in type IV allergies to s.c. Heparin preparations: A systematic review. Abstract CD 46 DDG meeting: P02/01.

Authors

Last updated on: 29.10.2020